Galderma recently announced final nine-month results from its phase 4 clinical trial confirming that the combination of Sculptra and Restylane Lyft or Contour delivers sustained improvement in facial appearance and high patient satisfaction for individuals facing aesthetic changes due to medication-driven weight loss.

The results, said clinical trial investigator Michael Somenek, MD, represent an evolution in how the aesthetics field can holistically support patients through their weight loss journey, both physically and emotionally.

Read more at Dermatology Times >>